To The Moon

Sign Up

ARKG Investment Tracker

Source from：<a href="https://ark-funds.com/funds/arkg/">official website</a> ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Veeva by 624 shares, the number of shares held increased 1.55% compared to the previous period and now represents 0.76% of the total position.
      39Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Amgen by 689 shares, the number of shares held increased 1.55% compared to the previous period and now represents 1.17% of the total position.
      85Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 403 shares, the number of shares held increased 1.58% compared to the previous period and now represents 0.91% of the total position.
      8Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Incyte by 2,106 shares, the number of shares held increased 1.57% compared to the previous period and now represents 1.04% of the total position.
      15Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 8,230 shares, the number of shares held increased 5.88% compared to the previous period and now represents 1.83% of the total position.
      25Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Atai Beckley Inc by 51,246 shares, the number of shares held increased 1.58% compared to the previous period and now represents 1.11% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 77,428 shares, the number of shares held increased 1.58% compared to the previous period and now represents 1.47% of the total position.
      57Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Intellia Therapeutics by 50,401 shares, the number of shares held increased 1.58% compared to the previous period and now represents 2.41% of the total position.
      27Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 29,588 shares, the number of shares held increased 1.58% compared to the previous period and now represents 2.68% of the total position.
      8Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 23,699 shares, the number of shares held increased 1.58% compared to the previous period and now represents 2.1% of the total position.
      1Comment
      Report
       
       
       
       

      Most Discussed